Journalists Zero In on ‘Certificate of Need’ Laws and Turbulent Obamacare Enrollment Season

KFF Health News senior correspondent Renuka Rayasam discussed gun violence in Bogalusa, Louisiana, on KALW’s Your Call on Dec. 19. Click here to hear Rayasam on Your Call. Read Rayasam’s “Guns, Race, and Profit: The Pain of America’s Other Epidemic,” co-reported with Fred Clasen-Kelly. KFF Health News rural health correspondent Andrew Jones discussed the implications…

Read More

How High is Too High? The Crippling Cost of Denial Rates

Patients should know exactly what’s covered and what it costs before receiving care. Doctors should be empowered to make medical decisions without interference from insurance companies. And the entire process should be designed to facilitate care, not obstruct it. The post How High is Too High? The Crippling Cost of Denial Rates appeared first on…

Read More

FDA Rejection Delays Regeneron From Competing With J&J, Pfizer in Multiple Myeloma

Regeneron Pharmaceuticals said the FDA cited no approvability concerns for its multiple myeloma drug, linvoseltamab, other than previously identified issues with a contract manufacturer. While linvoseltamab trails bispecific antibodies currently marketed by Johnson & Johnson and Pfizer, if approved, it could bring patients an earlier treatment option. The post FDA Rejection Delays Regeneron From Competing…

Read More